Elizabeth J Bell1, Suzette J Bielinski2, Jennifer L St Sauver2, Lin Y Chen3, Mary R Rooney4, Nicholas B Larson5, Paul Y Takahashi6, Aaron R Folsom7. 1. Department of Life Sciences, Optum, Eden Prairie, MN. Electronic address: elizabeth.bell@optum.com. 2. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 3. Cardiovascular Division, University of Minnesota Medical School, Minneapolis. 4. Department of Epidemiology, Johns Hopkins University, Baltimore, MD. 5. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN. 6. Division of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN. 7. Division of Epidemiology and Community Health, University of Minnesota's School of Public Health, Minneapolis.
Abstract
OBJECTIVE: To examine associations of cumulative exposure to proton pump inhibitors (PPIs) with total cardiovascular disease (CVD; composed of stroke, coronary heart disease, and heart failure [HF]) and HF alone in a cohort study of White and African American participants of the Atherosclerosis Risk in Communities (ARIC) study. METHODS: Use of PPIs was assessed by pill bottle inspection at visit 1 (January 1, 1987 to 1989) and up to 10 additional times before baseline (visit 5; 2011 to 2013). We calculated cumulative exposure to PPIs as days of use from visit 1 to baseline. Participants (n=4346 free of total CVD at visit 5; mean age, 75 years) were observed for incident total CVD and HF events through December 31, 2016. We used Cox regression to measure associations of PPIs with total CVD and HF. RESULTS: After adjustment for potential confounding variables, participants with a cumulative exposure to PPIs of more than 5.1 years had a 2.02-fold higher risk of total CVD (95% CI, 1.50 to 2.72) and a 2.21-fold higher risk of HF (95% CI, 1.51 to 3.23) than nonusers. CONCLUSION: Long-term PPI use was associated with twice the risk of total CVD and HF compared with nonusers. Our findings are in concordance with other research and suggest another reason to be cautious of PPI overuse.
OBJECTIVE: To examine associations of cumulative exposure to proton pump inhibitors (PPIs) with total cardiovascular disease (CVD; composed of stroke, coronary heart disease, and heart failure [HF]) and HF alone in a cohort study of White and African American participants of the Atherosclerosis Risk in Communities (ARIC) study. METHODS: Use of PPIs was assessed by pill bottle inspection at visit 1 (January 1, 1987 to 1989) and up to 10 additional times before baseline (visit 5; 2011 to 2013). We calculated cumulative exposure to PPIs as days of use from visit 1 to baseline. Participants (n=4346 free of total CVD at visit 5; mean age, 75 years) were observed for incident total CVD and HF events through December 31, 2016. We used Cox regression to measure associations of PPIs with total CVD and HF. RESULTS: After adjustment for potential confounding variables, participants with a cumulative exposure to PPIs of more than 5.1 years had a 2.02-fold higher risk of total CVD (95% CI, 1.50 to 2.72) and a 2.21-fold higher risk of HF (95% CI, 1.51 to 3.23) than nonusers. CONCLUSION: Long-term PPI use was associated with twice the risk of total CVD and HF compared with nonusers. Our findings are in concordance with other research and suggest another reason to be cautious of PPI overuse.
Authors: Wayne D Rosamond; Patricia P Chang; Chris Baggett; Anna Johnson; Alain G Bertoni; Eyal Shahar; Anita Deswal; Gerardo Heiss; Lloyd E Chambless Journal: Circ Heart Fail Date: 2012-01-23 Impact factor: 8.790
Authors: Riley Batchelor; Radya Kumar; Julia F M Gilmartin-Thomas; Ingrid Hopper; William Kemp; Danny Liew Journal: Aliment Pharmacol Ther Date: 2018-09-04 Impact factor: 8.171
Authors: Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless Journal: Am J Cardiol Date: 2008-02-14 Impact factor: 2.778
Authors: Pamela L Lutsey; Alvaro Alonso; Erin D Michos; Laura R Loehr; Brad C Astor; Josef Coresh; Aaron R Folsom Journal: Am J Clin Nutr Date: 2014-07-16 Impact factor: 7.045
Authors: Stephanie E Chiuve; Qi Sun; Gary C Curhan; Eric N Taylor; Donna Spiegelman; Walter C Willett; Joann E Manson; Kathryn M Rexrode; Christine M Albert Journal: J Am Heart Assoc Date: 2013-03-18 Impact factor: 5.501
Authors: Lucas C Pinheiro; Gustavo H Oliveira-Paula; Rafael L Portella; Danielle A Guimarães; Celio D de Angelis; Jose E Tanus-Santos Journal: Redox Biol Date: 2016-08-04 Impact factor: 11.799
Authors: So Young Kim; Dae Myoung Yoo; Mi Jung Kwon; Ji Hee Kim; Joo-Hee Kim; Joong Seob Lee; Hyo Geun Choi Journal: Int J Environ Res Public Health Date: 2022-08-18 Impact factor: 4.614